Enfuvirtide Acetate (T-20)
Product Name |
Enfuvirtide Acetate (T-20) |
Sequence |
CH3CO-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu |
Cas No. |
|
Molecular Formula |
C204H301N51O64 |
Molecular Weight |
4492 |
Purity (HPLC) |
98.0%min. |
Appearance |
White to off-white amorphous solid |
Single Impurity (HPLC) |
0.5%max |
Amino Acid Composition |
±10% of theoretical |
Peptide Content (N%) |
≥80.0% |
Water Content (Karl Fischer) |
≤8.0% |
TrifluoroAcetate Content(HPIC) |
≤12.0% |
MS (ESI) |
Consistent |
Mass Balance |
95.0~105.0% |
2. Description:
Enfuvirtide is an antiretroviral drug used in combination therapy for the treatment of HIV-1/AIDS. It binds to the first heptad-repeat (HR1) in the gp41 subunit of the viral envelope glycoprotein and prevents the conformational changes required for the fusion of viral and cellular membranes. It works by disrupting the HIV-1 molecular machinery at the final stage of fusion with the target cell, preventing uninfected cells from becoming infected.
在线联系供应商
Other supplier products
Enfuvirtide Acetate (T-20) | Product Name Enfuvirtide Acetate (T-20) Sequence CH3CO-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-... | |
Eledoisin Acetate | Product Name Eledoisin Acetate Sequence pGlu-Pro-Ser-Lys-Asp-Ala-Phe-Ile-Gly-Leu-Met-NH2 Cas No. 69-25-0 Molecular Formula ... | |
Bivalirudin Trifluoroacetate | Product Name Bivalirudin Trifluoroacetate Sequence D-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-OH... | |
Antide Acetate | Product Name Antide Acetate Sequence Ac-D-2-Nal-p-Chloro-D-Phe-β-(3-pyridyl)-D-Ala-Ser-Lys(nicotinoyl)-D-Lys(nicotinoyl)-Leu-Lys(i... | |
Alpha-Galactosidase a-Galactosidase From Aspergillus Niger | Basic Info Model NO.:9025-35-8 alpha-galactosidase CAS:9025-35-8 Enzyme Activity:5000 Trademark:Saichuang Origin:Wuhan, Guangzhou, Shenzhen, Ch... |